Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Feasible to create a stockpile of H5N1 vaccine

Countries and vaccine manufacturers agreed on Wednesday in a meeting at WHO that it may be feasible to create a stockpile of H5N1 vaccine, and to separately develop a mechanism to ensure broader access to pandemic influenza vaccine for developing countries in the advent of a pandemic.

30 Apr 2007

Ranbaxy receives approval to manufacture Pravastatin Sodium tablets in U.S.

Ranbaxy Pharmaceuticals has announced that RLL has received approval from the U.S. Food and Drug Administration to manufacture and market Pravastatin Sodium Tablets (Pravastatin), 10 mg, 20 mg, 40 mg and 80 mg, with 180-day market exclusivity in the U.S. healthcare system for the 80 mg strength.

27 Apr 2007

When it comes to bird flu - will Indonesia play the game?

Despite the fact that bird flu does not appear to have the news value it had a year ago, the deadly virus continues to circle the globe causing mayhem by killing humans and decimating bird populations.

26 Apr 2007

Wyeth Pharmaceuticals receives FDA approvable for Bazedoxifene for the prevention of postmenopausal osteoporosis

Wyeth Pharmaceuticals has announced that the U.S. Food and Drug Administration (FDA) has issued an approvable letter for bazedoxifene, a selective estrogen receptor modulator (SERM) for the prevention of postmenopausal osteoporosis.

26 Apr 2007

Babies are exposed to perfluorooctane sulfonate and perfluorooctanoate in the womb

An analysis of nearly 300 umbilical cord blood samples led by researchers at the Johns Hopkins Bloomberg School of Public Health shows that newborn babies are exposed to perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) while in the womb.

25 Apr 2007

WHO facilitates influenza vaccine technology transfer to developing countries

As part of a concerted effort to ensure more equitable access to a potential pandemic influenza vaccine, six developing countries are being awarded grants to establish in-country manufacturing capacity for influenza vaccine. The countries are Brazil, India, Indonesia, Mexico, Thailand and Viet Nam.

25 Apr 2007

NanoFrontiers: Visions for the Future of Nanotechnology

Controlling the properties and behavior of matter at the smallest scale, in effect, "domesticating atoms",can help to overcome some of the world's biggest challenges, concludes a new report on how diverse experts view the future of nanotechnology.

24 Apr 2007

Adjustable chairs reduce shoulder and neck pain

Adjustable-height chairs with ergonomically curved seats can significantly reduce neck and shoulder pain in garment workers, according to a new study in the April 20 issue of Spine.

24 Apr 2007

Indevus Pharmaceuticals submits supplemental NDA for VALSTAR

Indevus Pharmaceuticals has announced that it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) seeking approval to reintroduce VALSTAR in the United States.

20 Apr 2007

Local corticosteroid injection for carpal tunnel syndrom

A single corticosteroid injection in the wrist can offer at least a month of relief to people suffering from severe carpal tunnel syndrome, according to an updated review of studies by Canadian researchers.

20 Apr 2007

Micell Technologies presents data on novel drug-eluting stents

Micell Technologies has announced that the Company will be presenting data on use of its supercritical fluid (SCF) surface modification technology for drug-eluting stents at the upcoming Society for Biomaterials 2007 Annual Meeting, April 19-21 2007 in Chicago, Illinois.

19 Apr 2007

Nanoparticles could damage DNA and lead to cancer

Tissue studies indicate that nanoparticles, engineered materials about a billionth of a meter in size, could damage DNA and lead to cancer, according to research presented at the 2007 Annual Meeting of the American Association for Cancer Research.

18 Apr 2007

Cell Genesys reports data from clinical trials of GVAX immunotherapy for prostate cancer

Evaluation of antibody responses in patients with advanced prostate cancer from these studies shows that the GVAX cell-based immunotherapy induces antibody responses to a broad array of prostate cancer- associated antigens, including some not previously known to be associated with prostate cancer.

18 Apr 2007

Taking a jab at cancer by stimulating the immune system

As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress.

18 Apr 2007

Thrombogenics announces agreement with Millipore for commercialization of stem cell technology

ThromboGenics NV has announced that it has completed a global license agreement with Millipore Corporation under which ThromboGenics will exclusively license its technology for production of the proprietary stem cell culture medium marketed by Millipore as RESGRO(x).

17 Apr 2007

Indigo Orb autoDetect syringe wins medical design award

Indigo Orb, Inc. has announced that their Episure AutoDetect has received a 2007 Medical Design Excellence Award.

15 Apr 2007

Avista Capital acquires BioReliance from Invitrogen

Avista Capital Partners has announced it has completed its acquisition of BioReliance Corporation, a business unit of Invitrogen Corporation for approximately $210 million.

15 Apr 2007

Freedom from the egg holds much promise for new flu vaccines

An experimental flu vaccine made in insect cells – not in eggs, where flu vaccines currently available in the United States are grown – is safe and as effective as conventional vaccines in protecting people against the flu, according to results published in the April 11 issue of the Journal of the American Medical Association .

11 Apr 2007

Synergetics settles patent case

The parties have entered into a Settlement Agreement and a Manufacture and Supply Agreement to resolve both lawsuits and all claims between the parties.

11 Apr 2007